Reducing liver disease in children who undergo complex heart surgery

Trial focuses on whether drug udenafil can help prevent chronic liver problems in kids who require a Fontan procedure for congenital heart disease.

3:30 PM

Author | Beata Mostafavi

stethoscope lab note
Jacob Dwyer, Justine Ross, Michigan Medicine

Some children with complex congenital heart disease require an open-heart surgery known as the Fontan to reroute their body's blood flow, but undergoing the procedure means eventually experiencing some level of liver disease.

While reasons for Fontan-associated liver disease are unclear, experts believe the altered circulation from the procedure may impact blood flow throughout the liver and contribute to liver scarring.

Now, researchers from the Pediatric Heart Network are studying a potential solution to the prevalent complication.

Michigan Medicine teams presented early results from a trial testing whether drug udenafil can reduce liver stiffness that contributes to Fontan-related liver disease in children at the American Heart Association scientific sessions in Chicago.

"There are no treatments for Fontan-associated liver disease and it's universally present in this group of patients," said lead researcher Kurt Schumacher, M.D., a pediatric cardiologist at University of Michigan Health C.S. Mott Children's Hospital, of Michigan Medicine.

"Udenafil relaxes the pulmonary arteries allowing blood to flow through them more easily. This may be important in people who have Fontan circulation that lack a ventricle to pump blood through the pulmonary arteries."

The Fontan procedure is part of a series of reconstructive heart surgeries to help reroute blood flow for children with congenital heart disorders affecting one lower chamber of the heart – or single ventricle defects. These patients could have a smaller or underdeveloped chamber or be missing a valve due to heart problems like hypoplastic left heart syndrome or tricuspid atresia.

The trial included 88 enrolled adolescents from more than 20 centers who had undergone a Fontan procedure. Researchers wanted to see if relaxing the blood vessels in the lungs with udenafil would also allow the blood vessels in the liver to relax.

After 12 months, there was no evidence of reduced liver stiffness, or vessels being relaxed or less congested. However, blood tests detected significant decreases in ongoing scarring, or fibrosis, that can lead to more serious liver disease.   

Schumacher said the finding warrants a larger, longitudinal study.

"We don't understand yet how or whether this treatment will meaningfully help the liver, but perhaps by relaxing the pulmonary arteries, we are changing something about how congestion affects the liver and leads to scarring," Schumacher said.

"For a disease without treatments, anything that may affect the onset or progression of liver scarring is worth learning more about."

Funding: The trial was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health with financial support from the sponsor, Mezzion Pharma Co. Ltd.

More Articles About: Lab Notes All Research Topics Congenital Heart Disease CS Mott Children's Hospital Cardiac Surgery Growth and Development Pediatric Health Conditions Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Dinero is back to being an active toddler following a kidney transplant
Health Lab
Formula prescription helps 2-year-old receive kidney transplant
Dinero's pediatric nephrology team developed a tailored formula to address his mineral deficiencies due to his chronic kidney disease, maintain nutritional health and avoid dialysis.
heart organ yellow blue
Health Lab
Around 10% of deaths from coronary stenting, balloon angioplasty are preventable
Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.
Illustration of teenager lying in bed while images above depict an F grade on paper and classroom
Health Lab
2 in 3 parents say their adolescent or teen worries about how sick days may impact grades
National poll: 1 in 5 parents consider if their child needs a mental health day; 1 in 4 say attendance policies are challenging for kids with medical conditions
Photo of two silhouettes in a hallway
Health Lab
Most new doctors face some form of sexual harassment, even after #MeToo
Sexual harassment of all kinds is a common experience among first-year medical residents, also known as interns, especially those in surgical specialties, but it may be declining.
Four older women pose and smile
Health Lab
Unlocking the secrets of SuperAgers
People in their 80s and 90s with cognitive abilities similar to much younger people, called super agers, are taking part in a national study of their brain health.
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.